Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christoph Wanner

Showing results (111-120 of 785) with videos related to

Pageof 79
Sort By:
Current Pharmaceutical Design|December 9, 2014
The Fabry cardiomyopathy - diagnostic approach and current treatmentFrank Weidemann, Georg Ertl, Christoph Wanner, et al.
Journal of Renal Nutrition : the Official Journal of the Council on Renal Nutrition of the National Kidney Foundation|January 15, 2014
Toward individualized cholesterol-lowering treatment in end-stage renal diseaseGuenther Silbernagel, Iris Baumgartner, Christoph Wanner, et al.
Journal of Contaminant Hydrology|February 21, 2012
Assessing the Cr(VI) reduction efficiency of a permeable reactive barrier using Cr isotope measurements and 2D reactive transport modelingChristoph Wanner, Sonja Zink, Urs Eggenberger, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 1, 2020
Editorial: The role of sodium-glucose cotransporter 2 inhibitors in the management of chronic kidney diseaseHiddo J L Heerspink, Denis Fouque, Christoph Wanner
Blood Purification|December 17, 2015
Long-Term Evaluation of Colestilan in Chronic Kidney Disease Stage 5 Dialysis Patients with HyperphosphataemiaFrancesco Locatelli, Goce Spasovski, Nada Dimkovic, et al.
Current Medical Research and Opinion|August 22, 2025
Safety of empagliflozin treatment in four clinical studies: a plain language summaryChristoph Wanner, Nathalia Duarte, Vikram Thanam, et al.
Kidney International|June 25, 2018
Chronic kidney disease and arrhythmias: highlights from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies ConferenceChristoph Wanner, Charles A Herzog, Mintu P Turakhia, et al.
Kidney & Blood Pressure Research|June 22, 2011
Chronic renal failure and its complicationsVladimir Tesař, Christoph Wanner, Thomas Quaschning, et al.
The New England Journal of Medicine|December 23, 2011
Long interdialytic interval and mortalityKarlijn J van Stralen, Christoph Wanner, Kitty J Jager
Clinical Kidney Journal|April 17, 2020
Comparison of different algorithms for the assessment of cardiovascular risk after kidney transplantation by the time of entering waiting listAnna Laura Herzog, Charis Kalogirou, Christoph Wanner, et al.
Pageof 79

Showing results (111-120 of 785) with videos related to

Sort By:
Pageof 79
Current Pharmaceutical Design|December 9, 2014
The Fabry cardiomyopathy - diagnostic approach and current treatmentFrank Weidemann, Georg Ertl, Christoph Wanner, et al.
Journal of Renal Nutrition : the Official Journal of the Council on Renal Nutrition of the National Kidney Foundation|January 15, 2014
Toward individualized cholesterol-lowering treatment in end-stage renal diseaseGuenther Silbernagel, Iris Baumgartner, Christoph Wanner, et al.
Journal of Contaminant Hydrology|February 21, 2012
Assessing the Cr(VI) reduction efficiency of a permeable reactive barrier using Cr isotope measurements and 2D reactive transport modelingChristoph Wanner, Sonja Zink, Urs Eggenberger, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 1, 2020
Editorial: The role of sodium-glucose cotransporter 2 inhibitors in the management of chronic kidney diseaseHiddo J L Heerspink, Denis Fouque, Christoph Wanner
Blood Purification|December 17, 2015
Long-Term Evaluation of Colestilan in Chronic Kidney Disease Stage 5 Dialysis Patients with HyperphosphataemiaFrancesco Locatelli, Goce Spasovski, Nada Dimkovic, et al.
Current Medical Research and Opinion|August 22, 2025
Safety of empagliflozin treatment in four clinical studies: a plain language summaryChristoph Wanner, Nathalia Duarte, Vikram Thanam, et al.
Kidney International|June 25, 2018
Chronic kidney disease and arrhythmias: highlights from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies ConferenceChristoph Wanner, Charles A Herzog, Mintu P Turakhia, et al.
Kidney & Blood Pressure Research|June 22, 2011
Chronic renal failure and its complicationsVladimir Tesař, Christoph Wanner, Thomas Quaschning, et al.
The New England Journal of Medicine|December 23, 2011
Long interdialytic interval and mortalityKarlijn J van Stralen, Christoph Wanner, Kitty J Jager
Clinical Kidney Journal|April 17, 2020
Comparison of different algorithms for the assessment of cardiovascular risk after kidney transplantation by the time of entering waiting listAnna Laura Herzog, Charis Kalogirou, Christoph Wanner, et al.
Pageof 79